Issue: Vol. 2, No. 12, June 30, 2015

Table of Contents – The MedTech Strategist, Vol. 2, No. 12, June 30, 2015 (40 Pages):

• Perspective: “Specialty Drug Pricing Pushback: Is this the Canary in the Mineshaft for Medtech?” by David Cassak
• Under the Lens: “Elixir Medical’s Contrarian Play in Cardiology: Go Bioresorbable or Go Home,” by Stephen Levin
• Market Snapshot: “Cartilage Repair: Next-Gen Products Tackle the Challenge,” by Mary Thompson
• Health Economics: “The Specialty Drug Price Debate: Should Medtech Be Worried?” by David Cassak
• Medtech Financing: “Half-Year Financing Recap: Crossover Investors Boost Device/Dx Financing; IPO Exits Trump M&A,” by Wendy Diller
• Start-Ups to Watch: “Autonomic Technologies: Neurostimulation Alleviates Intractable Headache Pain,” by Wendy Diller
• Start-Ups to Watch: “Renephra: Home-Based Fluid Removal for Fluid Overload and Chronic Edema,” by Mary Stuart
• Start-Ups to Watch: “Sandstone Diagnostics: A Home-Based Male Fertility Test Becomes a Health Tracker,” by Mary Stuart